CK-MB Reagent Kit (Quantitative)

Product Name: CK-MB Reagent Kit (Quantitative)

Method: Laternal-Flow technology (Fluorescent Immunochromatographic)

Product Models: 5 tests/box, 25 tests/box, 40 tests/box, 100 tests/box

CFDA Registration No.: 20152400172

Certification: CE, SGS ISO13485, ISO9001

Matching Equipment's: Solid Phase Fluorescence Immunoassay System (KOFA Brand).

Introduction: This reagent kit is base on fluorescent chromatographic technology, supporting the quantitative rapid test of CK-MB level in the serum/plasma, and CK-MB is the marker for the early diagnosis of acute myocardial infraction (AMI)

CK-MB Technical Parameters:

The advantages of CK-MB

1. Advanced fluoroimmunoassay quantitative testing platform, make accurate and quantitative rapid test of CK-MB level available

2. Low cost and rapid test, can get the quantitative and reliable results in 15 minutes, shorten the testing turnaround time.

3. The testing results of this CK-MB kit have good correlation with that of Roche diagnostics (compared with thousands of cases)

4. Simple operation and rapid test, can meet the need of various departments.

5. The effective marker for the early diagnosis of the acute myocardial infraction (AMI)

Applicable Departments: Departments of cardiology, surgery, geriatrics respiratory, obstetrics, pediatrics, emergency ward and ICU.